Exelixis
EXELExelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Exelixis
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/1/2026 | Sell | Eckhardt, Sue Gail | Director | $50.1 | $491,974 |
| 6/1/2026 | Sell | Wyszomierski, Jack L. | Director | $50.6 | $198,409 |
| 5/26/2026 | Sell | Aftab, Dana | EVP, Research and Development | $50.4 | $2,187,758 |
| 5/20/2026 | Sell | Haley, Patrick J. | EVP, Commercial | $49.8 | $1,599,399 |
| 5/18/2026 | Sell | Hefti, Brenda | SVP and General Counsel | $50.2 | $332,641 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)